The proprietary science behind Vigilant Biosciences® tests uses unique biomarkers that can indicate the presence of oral and oropharyngeal cancer, potentially before physical symptoms are present. Vigilant Biosciences continues to conduct research and development to expand our approach to additional platforms and applications to meet the critical and growing need for earlier intervention of this disease and potentially other cancers.

Work With Us on Future R&D